| 2026-06-25 |
PainReform LTD |
PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark prf-tech.com ↗ |
| 2026-05-26 |
PainReform LTD |
PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study prf-tech.com ↗ |
| 2024-12-27 |
PainReform LTD |
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110 prf-tech.com ↗ |
| 2024-11-20 |
PainReform LTD |
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial prf-tech.com ↗ |
| 2024-09-11 |
PainReform LTD |
PainReform Ltd. Confirms Sutures Compatibilityin Human Clinical Trials for PRF-110 prf-tech.com ↗ |
| 2024-08-21 |
PainReform LTD |
PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures prf-tech.com ↗ |
| 2024-08-20 |
PainReform LTD |
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study prf-tech.com ↗ |
| 2024-08-07 |
PainReform LTD |
PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses prf-tech.com ↗ |
| 2024-08-05 |
PainReform LTD |
PainReform Ltd. Announces Favorable Wound Healing Datain Human Clinical Trials for PRF-110 prf-tech.com ↗ |
| 2024-08-01 |
PainReform LTD |
PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature prf-tech.com ↗ |
| 2024-07-24 |
PainReform LTD |
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing prf-tech.com ↗ |
| 2024-06-26 |
PainReform LTD |
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110 prf-tech.com ↗ |
| 2024-05-08 |
PainReform LTD |
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com prf-tech.com ↗ |
| 2024-04-02 |
PainReform LTD |
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy prf-tech.com ↗ |
| 2024-01-03 |
PainReform LTD |
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief prf-tech.com ↗ |
| 2023-09-11 |
PainReform LTD |
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trialto Evaluate PRF-110 in Patients Undergoing Bunionectomy SurgeryFollowing Positive FDA Review of Drug Master File prf-tech.com ↗ |
| 2023-06-07 |
PainReform LTD |
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery prf-tech.com ↗ |
| 2023-05-18 |
PainReform LTD |
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery prf-tech.com ↗ |
| 2023-05-01 |
PainReform LTD |
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trialof PRF-110 in Patients Undergoing Bunionectomy Surgery prf-tech.com ↗ |
| 2023-03-16 |
PainReform LTD |
PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomy prf-tech.com ↗ |
| 2023-03-14 |
PainReform LTD |
PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery prf-tech.com ↗ |
| 2022-11-08 |
PainReform LTD |
PainReform Provides Further Update on Manufacturing of PRF-110 prf-tech.com ↗ |
| 2022-10-04 |
PainReform LTD |
PainReform Provides PRF-110 Manufacturing Update prf-tech.com ↗ |
| 2022-03-17 |
PainReform LTD |
PainReform Provides Year-End Business Update; On track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022 prf-tech.com ↗ |
| 2021-03-18 |
PainReform LTD |
PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief prf-tech.com ↗ |
| 2021-01-06 |
PainReform LTD |
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110 prf-tech.com ↗ |
| 2020-10-19 |
PainReform LTD |
PainReform Highlights Surgical Advantages of PRF-110 prf-tech.com ↗ |
|